New hope drug studied for Tough-to-Treat lung cancer
NCT ID NCT06282991
Summary
This study looked back at how well the oral drug lorlatinib worked for 73 Taiwanese patients with a specific genetic type of advanced lung cancer. All participants had already tried at least one other treatment that stopped working. The goal was to see how effective and safe lorlatinib was in real-world medical practice, outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHANG GUNG MEMORIAL HOSPITAL Kaohsiung Branch
Kaohsiung City, 83301, Taiwan
-
Chang Gung Memorial Hospital - Linkou Branch
Taoyuan, 333, Taiwan
-
Chung Shan Medical University Hospital
Taichung, 402, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Taichung Veterans General Hospital
Taichung, 407219, Taiwan
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
Conditions
Explore the condition pages connected to this study.